首页 > 最新文献

Journal of molecular and cellular cardiology最新文献

英文 中文
Calpain cleavage of Junctophilin-2 during cardiac stress: The G482/T483 site is not to be blamed 钙蛋白酶在心脏应激过程中裂解 Junctophilin-2:G482/T483 位点不应受到指责a。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.005
Long-Sheng Song, Duane D. Hall, Jinxi Wang
{"title":"Calpain cleavage of Junctophilin-2 during cardiac stress: The G482/T483 site is not to be blamed","authors":"Long-Sheng Song, Duane D. Hall, Jinxi Wang","doi":"10.1016/j.yjmcc.2024.12.005","DOIUrl":"10.1016/j.yjmcc.2024.12.005","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 60-61"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142845950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optogenetic stimulation and simultaneous optical mapping of membrane potential and calcium transients in human engineered cardiac spheroids 人工程心脏球体膜电位和钙瞬态的光遗传刺激和同步光学定位。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.003
Bijay Guragain , Hanyu Zhang , Yalin Wu , Yongyu Wang , Yuhua Wei , Garrett A. Wood , Lei Ye , Gregory P. Walcott , Jianyi Zhang (Jay) , Jack M. Rogers
Optogenetic stimulation combined with optical mapping of membrane potential (Vm) and calcium transients (CaT) is a powerful electrophysiological tool. We developed a novel experimental platform in which tissue is stimulated optogenetically while Vm and CaT are imaged simultaneously. The Vm indicator is an organic dye, while the CaT indicator is genetically encoded. We used cardiac spheroids containing cardiomyocytes and fibroblasts differentiated from human induced pluripotent stem cells as model tissue. The spheroids were genetically encoded with an optogenetic actuator, CheRiff, and the calcium indicator jRCaMP1b. The Vm indicator was the organic dye RH237. CheRiff was excited using blue light (450 nm), and both RH237 and jRCaMP1b were excited using a single band of green light (either 525–575 nm or 558–575 nm). Fluorescence emission was split and imaged by two cameras (CaT: 595–665 nm; Vm: >700 nm). The spheroids were successfully stimulated optogenetically and Vm and CaT were recorded simultaneously without cross-talk using both excitation light bands. The 525–575 nm band produced higher signal-to-noise ratios than the 558–575 nm band, but caused a slight increase in tissue excitability because of CheRiff activation. The optogenetic actuator and CaT indicator are genetically encoded and can be expressed in engineered tissue constructs. In contrast, the Vm indicator is an organic dye that can stain any tissue. This system is well-suited for studying coupling between engineered tissue grafts and host tissue because the two tissue types can be stimulated independently, and tissue activation can be unambiguously attributed to either graft or host.
光遗传刺激结合膜电位(Vm)和钙离子瞬态(CaT)光学图谱是一种强大的电生理工具。我们开发了一种新颖的实验平台,在该平台上,组织受到光遗传刺激的同时,Vm 和 CaT 也会同时成像。Vm 指示剂是一种有机染料,而 CaT 指示剂是基因编码的。我们使用包含由人类诱导多能干细胞分化而成的心肌细胞和成纤维细胞的心脏球体作为模型组织。这些球形体在基因上编码了光遗传致动器 CheRiff 和钙指示剂 jRCaMP1b。Vm指示剂是有机染料RH237。CheRiff 使用蓝光(450 纳米)激发,RH237 和 jRCaMP1b 使用单波段绿光(525-575 纳米或 558-575 纳米)激发。荧光发射由两台照相机分割和成像(CaT:595-665 nm;Vm:>700 nm)。成功地对球体进行了光遗传刺激,并使用两个激发光波段同时记录了 Vm 和 CaT,没有发生串扰。525-575 nm 波段产生的信噪比高于 558-575 nm 波段,但由于 CheRiff 的激活,组织兴奋性略有增加。光遗传致动器和 CaT 指示器是基因编码的,可以在工程组织构建物中表达。相比之下,Vm 指示剂是一种有机染料,可以染色任何组织。该系统非常适合研究工程组织移植物与宿主组织之间的耦合,因为这两种组织类型可以独立受到刺激,而且组织激活可以明确归因于移植物或宿主。
{"title":"Optogenetic stimulation and simultaneous optical mapping of membrane potential and calcium transients in human engineered cardiac spheroids","authors":"Bijay Guragain ,&nbsp;Hanyu Zhang ,&nbsp;Yalin Wu ,&nbsp;Yongyu Wang ,&nbsp;Yuhua Wei ,&nbsp;Garrett A. Wood ,&nbsp;Lei Ye ,&nbsp;Gregory P. Walcott ,&nbsp;Jianyi Zhang (Jay) ,&nbsp;Jack M. Rogers","doi":"10.1016/j.yjmcc.2024.12.003","DOIUrl":"10.1016/j.yjmcc.2024.12.003","url":null,"abstract":"<div><div>Optogenetic stimulation combined with optical mapping of membrane potential (Vm) and calcium transients (CaT) is a powerful electrophysiological tool. We developed a novel experimental platform in which tissue is stimulated optogenetically while Vm and CaT are imaged simultaneously. The Vm indicator is an organic dye, while the CaT indicator is genetically encoded. We used cardiac spheroids containing cardiomyocytes and fibroblasts differentiated from human induced pluripotent stem cells as model tissue. The spheroids were genetically encoded with an optogenetic actuator, CheRiff, and the calcium indicator jRCaMP1b. The Vm indicator was the organic dye RH237. CheRiff was excited using blue light (450 nm), and both RH237 and jRCaMP1b were excited using a single band of green light (either 525–575 nm or 558–575 nm). Fluorescence emission was split and imaged by two cameras (CaT: 595–665 nm; Vm: &gt;700 nm). The spheroids were successfully stimulated optogenetically and Vm and CaT were recorded simultaneously without cross-talk using both excitation light bands. The 525–575 nm band produced higher signal-to-noise ratios than the 558–575 nm band, but caused a slight increase in tissue excitability because of CheRiff activation. The optogenetic actuator and CaT indicator are genetically encoded and can be expressed in engineered tissue constructs. In contrast, the Vm indicator is an organic dye that can stain any tissue. This system is well-suited for studying coupling between engineered tissue grafts and host tissue because the two tissue types can be stimulated independently, and tissue activation can be unambiguously attributed to either graft or host.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 51-59"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deficiency of Sox7 leads to congenital aortic stenosis via abnormal valve remodeling Sox7缺乏通过异常瓣膜重构导致先天性主动脉狭窄。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.11.015
Weiqi Feng , Nanchao Hong , Yizhuo Wu , Junxin Huang , Qi Zhang , Guizhu Liu , Ziling Qian , Yinghui Chen , Lihui Jin , Xiaowei Ding , Pengjun Zhao , Alex F. Chen , Yu Yu
Abnormal valve development is the most common congenital heart malformation. The transcription factor Sox7 plays a critical role in the development of vascular and cardiac septation. However, it remains unclear whether Sox7 is required for heart valve development. In the present study, Sox7 was strongly expressed in the endocardial and mesenchymal cells of the developing aortic valve in mice and humans, and that endocardial cell specific deletion of Sox7 (Nfatc1 Cre;Sox7fl/fl) in mice leads to congenital aortic stenosis basing on our echocardiography data and multiple staining results. Mechanistically, Sox7 influences extracellular matrix (ECM) remodeling of the valve through regulating MMP9. Meanwhile, Sox7 also affects other valvular remodeling processes, including apoptosis and proliferation of valvular cells in Sox7 deficiency mice. Similarly, in valvular interstitial cells (VICs), Sox7 overexpression increased the protein levels of cleaved caspase3 and TUNEL-positive VICs, while Ki67-positive VICs decreased. The reverse trend was observed in VICs with Sox7 deficiency. Significant enhancement of Rbm25 transcriptional levels was observed in the Sox7 overexpression group, and the mRNA and protein levels of calcification markers such as Osterix, Osteopontin and Runx2 were reduced. The reverse trend was observed in VICs with Sox7 deficiency. Von Kossa staining and Alizarin Red staining also demonstrated that sever calcification in Nfatc1 Cre;Sox7fl/fl mice. Moreover, we detected the Sox7 protein expression in human fetal aortic valves in patients with aortic stenosis, in which Sox7 positive mesenchymal cells were decreased. Taken together, these findings identify Sox7 as a potential pathogenic gene responsible for congenital aortic stenosis in human. Our study provides novel strategies for the diagnosis and treatment of congenital valvular malformation.
瓣膜发育异常是最常见的先天性心脏畸形。转录因子 Sox7 在血管和心脏隔膜的发育过程中起着至关重要的作用。然而,目前仍不清楚心脏瓣膜的发育是否需要Sox7。根据我们的超声心动图数据和多重染色结果,小鼠心内膜细胞特异性缺失Sox7(Nfatc1 Cre;Sox7fl/fl)会导致先天性主动脉瓣狭窄。从机制上讲,Sox7 通过调节 MMP9 影响瓣膜细胞外基质(ECM)的重塑。同时,Sox7 还影响其他瓣膜重塑过程,包括 Sox7 缺乏小鼠瓣膜细胞的凋亡和增殖。同样,在瓣膜间质细胞(VICs)中,Sox7过表达会增加裂解caspase3和TUNEL阳性VICs的蛋白水平,而Ki67阳性VICs则会减少。在缺乏 Sox7 的 VIC 中则观察到相反的趋势。在 Sox7 过表达组中观察到 Rbm25 转录水平显著提高,而 Osterix、Osteopontin 和 Runx2 等钙化标志物的 mRNA 和蛋白水平降低。而在Sox7缺乏的VIC中则观察到相反的趋势。Von Kossa染色和茜素红染色也证明了Nfatc1 Cre;Sox7fl/fl小鼠的严重钙化。此外,我们还在主动脉瓣狭窄患者的胎儿主动脉瓣中检测到了 Sox7 蛋白表达,其中 Sox7 阳性的间充质细胞减少。综上所述,这些发现确定了 Sox7 是导致人类先天性主动脉瓣狭窄的潜在致病基因。我们的研究为先天性瓣膜畸形的诊断和治疗提供了新的策略。
{"title":"Deficiency of Sox7 leads to congenital aortic stenosis via abnormal valve remodeling","authors":"Weiqi Feng ,&nbsp;Nanchao Hong ,&nbsp;Yizhuo Wu ,&nbsp;Junxin Huang ,&nbsp;Qi Zhang ,&nbsp;Guizhu Liu ,&nbsp;Ziling Qian ,&nbsp;Yinghui Chen ,&nbsp;Lihui Jin ,&nbsp;Xiaowei Ding ,&nbsp;Pengjun Zhao ,&nbsp;Alex F. Chen ,&nbsp;Yu Yu","doi":"10.1016/j.yjmcc.2024.11.015","DOIUrl":"10.1016/j.yjmcc.2024.11.015","url":null,"abstract":"<div><div>Abnormal valve development is the most common congenital heart malformation. The transcription factor <em>Sox7</em> plays a critical role in the development of vascular and cardiac septation. However, it remains unclear whether <em>Sox7</em> is required for heart valve development. In the present study, Sox7 was strongly expressed in the endocardial and mesenchymal cells of the developing aortic valve in mice and humans, and that endocardial cell specific deletion of Sox7 (Nfatc1 Cre;Sox7<sup>fl/fl</sup>) in mice leads to congenital aortic stenosis basing on our echocardiography data and multiple staining results. Mechanistically, Sox7 influences extracellular matrix (ECM) remodeling of the valve through regulating MMP9. Meanwhile, Sox7 also affects other valvular remodeling processes, including apoptosis and proliferation of valvular cells in Sox7 deficiency mice. Similarly, in valvular interstitial cells (VICs), Sox7 overexpression increased the protein levels of cleaved caspase3 and TUNEL-positive VICs, while Ki67-positive VICs decreased. The reverse trend was observed in VICs with Sox7 deficiency. Significant enhancement of Rbm25 transcriptional levels was observed in the Sox7 overexpression group, and the mRNA and protein levels of calcification markers such as Osterix, Osteopontin and Runx2 were reduced. The reverse trend was observed in VICs with Sox7 deficiency. Von Kossa staining and Alizarin Red staining also demonstrated that sever calcification in Nfatc1 Cre;Sox7<sup>fl/fl</sup> mice. Moreover, we detected the Sox7 protein expression in human fetal aortic valves in patients with aortic stenosis, in which Sox7 positive mesenchymal cells were decreased. Taken together, these findings identify Sox7 as a potential pathogenic gene responsible for congenital aortic stenosis in human. Our study provides novel strategies for the diagnosis and treatment of congenital valvular malformation.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 81-94"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT6 promotes angiogenesis by enhancing VEGFA secretion via demyristoylation in endothelial cell SIRT6通过内皮细胞的脱乳酰基化促进VEGFA分泌,从而促进血管生成。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.006
Runyang Feng , Shuangshuang Chen , Shichao Duan , Zhenyang Guo , Na Wu , Hangnan Hong , Zheyan Fang , Litao Wang , Yuxin Du , Lin Wu , Xin Zhong , Yiqing Hu , Zhentao Zhang , Mukaddas Abdurahman , Peng Li , Hua Li , Junbo Ge
Angiogenesis plays a pivotal role in ischemic cardiovascular disease, accompanied by epigenetic regulation during this process. Sirtuin 6 (SIRT6) has been implicated in the regulation of DNA repair, transcription and aging, with its deacetylase activity fully studied. However, the role of SIRT6 demyristoylase activity remains less clear, with even less attention given to its myristoylated substrates. In this study, we report that endothelial specific SIRT6 knockout attenuated angiogenesis in mice, while SIRT6 was observed to promote migration and tube formation in endothelial cell. Notably, we further determined that SIRT6 affects the intracellular VEGFA and global myristoylation level under hypoxia. Moreover, ALK14 (myristic acids analogue) treatment and SIRT6 knockdown results in a significant decrease in VEGFA secretion under hypoxia, implying the involvement of SIRT6 demyristoylase activity in angiogenesis. Mechanistically, CLICK IT assay verified that VEGFA is a myristoylated substrate of SIRT6. Further, overexpression of SIRT6 mutants (R65A, G60A and H133Y) results in profound differences in VEGFA secretion, indicating that SIRT6 promotes VEGFA secretion through demyristoylation but not deacetylation. Finally, overexpression of SIRT6 rescued the diminishment of endothelial migration, tube formation and sprouting caused by ALK14 treatment. Overall, our study demonstrates that SIRT6 regulates angiogenesis by demyristoylating VEGFA and increasing VEGFA secretion. Therefore, modulation of SIRT6 demyristoylase activity may represent a therapeutic strategy for ischemic cardiovascular disease.
血管生成在缺血性心血管疾病中起着关键作用,在这一过程中伴随着表观遗传调控。Sirtuin 6 (SIRT6)参与DNA修复、转录和衰老的调控,其去乙酰化酶活性已被充分研究。然而,SIRT6去肉豆蔻酰基酶活性的作用仍然不太清楚,对其肉豆蔻酰基化底物的关注甚至更少。在这项研究中,我们报道了内皮特异性SIRT6敲除可以减弱小鼠血管生成,而SIRT6可以促进内皮细胞的迁移和管的形成。值得注意的是,我们进一步确定SIRT6在缺氧条件下影响细胞内VEGFA和整体肉豆肉酰化水平。此外,ALK14(肉豆蔻酸类似物)处理和SIRT6敲低可导致缺氧条件下VEGFA分泌显著减少,这表明SIRT6去myristoylase活性参与血管生成。在机制上,CLICK IT试验证实VEGFA是SIRT6的肉豆醇化底物。此外,SIRT6突变体(R65A、G60A和H133Y)的过表达导致VEGFA分泌的显著差异,表明SIRT6通过去乳酰基化而不是去乙酰化促进VEGFA分泌。最后,SIRT6的过表达挽救了由ALK14处理引起的内皮迁移、管形成和发芽的减少。总之,我们的研究表明SIRT6通过去乳突化VEGFA和增加VEGFA分泌来调节血管生成。因此,调节SIRT6去淀粉酰化酶活性可能是缺血性心血管疾病的一种治疗策略。
{"title":"SIRT6 promotes angiogenesis by enhancing VEGFA secretion via demyristoylation in endothelial cell","authors":"Runyang Feng ,&nbsp;Shuangshuang Chen ,&nbsp;Shichao Duan ,&nbsp;Zhenyang Guo ,&nbsp;Na Wu ,&nbsp;Hangnan Hong ,&nbsp;Zheyan Fang ,&nbsp;Litao Wang ,&nbsp;Yuxin Du ,&nbsp;Lin Wu ,&nbsp;Xin Zhong ,&nbsp;Yiqing Hu ,&nbsp;Zhentao Zhang ,&nbsp;Mukaddas Abdurahman ,&nbsp;Peng Li ,&nbsp;Hua Li ,&nbsp;Junbo Ge","doi":"10.1016/j.yjmcc.2024.12.006","DOIUrl":"10.1016/j.yjmcc.2024.12.006","url":null,"abstract":"<div><div>Angiogenesis plays a pivotal role in ischemic cardiovascular disease, accompanied by epigenetic regulation during this process. Sirtuin 6 (SIRT6) has been implicated in the regulation of DNA repair, transcription and aging, with its deacetylase activity fully studied. However, the role of SIRT6 demyristoylase activity remains less clear, with even less attention given to its myristoylated substrates. In this study, we report that endothelial specific SIRT6 knockout attenuated angiogenesis in mice, while SIRT6 was observed to promote migration and tube formation in endothelial cell. Notably, we further determined that SIRT6 affects the intracellular VEGFA and global myristoylation level under hypoxia. Moreover, ALK14 (myristic acids analogue) treatment and SIRT6 knockdown results in a significant decrease in VEGFA secretion under hypoxia, implying the involvement of SIRT6 demyristoylase activity in angiogenesis. Mechanistically, CLICK IT assay verified that VEGFA is a myristoylated substrate of SIRT6. Further, overexpression of SIRT6 mutants (R65A, G60A and H133Y) results in profound differences in VEGFA secretion, indicating that SIRT6 promotes VEGFA secretion through demyristoylation but not deacetylation. Finally, overexpression of SIRT6 rescued the diminishment of endothelial migration, tube formation and sprouting caused by ALK14 treatment. Overall, our study demonstrates that SIRT6 regulates angiogenesis by demyristoylating VEGFA and increasing VEGFA secretion. Therefore, modulation of SIRT6 demyristoylase activity may represent a therapeutic strategy for ischemic cardiovascular disease.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 104-117"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual inhibition of Mst1 and Mst2 exacerbates cardiac dysfunction during pressure overload stress in mice
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.009
Jin Guan , Nadezhda Fefelova , Peiyong Zhai , Yoshiyuki Ikeda , Takanobu Yamamoto , Satvik Mareedu , Jamie Francisco , Lai-Hua Xie , Dae-sik Lim , Dominic P. Del Re
Heart failure remains a leading cause of morbidity and mortality worldwide. The evolutionarily conserved Hippo-Yap signaling pathway regulates cardiac responses to stress and progression to heart failure. Mst1 and Mst2 are the core Hippo pathway kinases, yet their role within chronically stressed cardiomyocytes remains largely unknown. Genetic mouse models revealed that the extent of Mst1/2 inhibition elicits opposing effects on stress-induced cardiac dysfunction. Yap-TEAD1 activation, cell cycling, and hallmarks of cardiomyocyte dedifferentiation, which can impair contractile function during sustained stress, were enhanced in Mst1/2 double knockout hearts. These findings implicate a physiological function of Mst1/2 to promote cardiomyocyte maturity in the adult heart.
{"title":"Dual inhibition of Mst1 and Mst2 exacerbates cardiac dysfunction during pressure overload stress in mice","authors":"Jin Guan ,&nbsp;Nadezhda Fefelova ,&nbsp;Peiyong Zhai ,&nbsp;Yoshiyuki Ikeda ,&nbsp;Takanobu Yamamoto ,&nbsp;Satvik Mareedu ,&nbsp;Jamie Francisco ,&nbsp;Lai-Hua Xie ,&nbsp;Dae-sik Lim ,&nbsp;Dominic P. Del Re","doi":"10.1016/j.yjmcc.2024.12.009","DOIUrl":"10.1016/j.yjmcc.2024.12.009","url":null,"abstract":"<div><div>Heart failure remains a leading cause of morbidity and mortality worldwide. The evolutionarily conserved Hippo-Yap signaling pathway regulates cardiac responses to stress and progression to heart failure. Mst1 and Mst2 are the core Hippo pathway kinases, yet their role within chronically stressed cardiomyocytes remains largely unknown. Genetic mouse models revealed that the extent of Mst1/2 inhibition elicits opposing effects on stress-induced cardiac dysfunction. Yap-TEAD1 activation, cell cycling, and hallmarks of cardiomyocyte dedifferentiation, which can impair contractile function during sustained stress, were enhanced in Mst1/2 double knockout hearts. These findings implicate a physiological function of Mst1/2 to promote cardiomyocyte maturity in the adult heart.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 133-136"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular vesicle therapeutics for cardiac repair 用于心脏修复的细胞外囊泡疗法。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.11.005
Yilan Hu , Weihang Zhang , Shah Rukh Ali , Koji Takeda , Torsten Peter Vahl , Donghui Zhu , Yi Hong , Ke Cheng
Extracellular vesicles (EVs) are cell-secreted heterogeneous vesicles that play crucial roles in intercellular communication and disease pathogenesis. Due to their non-tumorigenicity, low immunogenicity, and therapeutic potential, EVs are increasingly used in cardiac repair as cell-free therapy. There exist multiple steps for the design of EV therapies, and each step offers many choices to tune EV properties. Factors such as EV source, cargo, loading methods, routes of administration, surface modification, and biomaterials are comprehensively considered to achieve specific goals. PubMed and Google Scholar were searched in this review, 89 articles related to EV-based cardiac therapy over the past five years (2019 Jan - 2023 Dec) were included, and their key steps in designing EV therapies were counted and analyzed. We aim to provide a comprehensive overview that can serve as a reference guide for researchers to design EV-based cardiac therapies.
细胞外囊泡(EVs)是细胞分泌的异质性囊泡,在细胞间通信和疾病发病机制中发挥着至关重要的作用。由于其无致癌性、低免疫原性和治疗潜力,EVs 作为无细胞疗法正越来越多地用于心脏修复。EV疗法的设计有多个步骤,每个步骤都提供了许多调整EV特性的选择。为了实现特定的目标,需要综合考虑 EV 来源、货物、装载方法、给药途径、表面修饰和生物材料等因素。本综述检索了 PubMed 和 Google Scholar,收录了过去五年(2019 年 1 月至 2023 年 12 月)与基于 EV 的心脏疗法相关的 89 篇文章,并对其设计 EV 疗法的关键步骤进行了统计和分析。我们旨在提供一份全面的综述,为研究人员设计基于 EV 的心脏疗法提供参考指南。
{"title":"Extracellular vesicle therapeutics for cardiac repair","authors":"Yilan Hu ,&nbsp;Weihang Zhang ,&nbsp;Shah Rukh Ali ,&nbsp;Koji Takeda ,&nbsp;Torsten Peter Vahl ,&nbsp;Donghui Zhu ,&nbsp;Yi Hong ,&nbsp;Ke Cheng","doi":"10.1016/j.yjmcc.2024.11.005","DOIUrl":"10.1016/j.yjmcc.2024.11.005","url":null,"abstract":"<div><div>Extracellular vesicles (EVs) are cell-secreted heterogeneous vesicles that play crucial roles in intercellular communication and disease pathogenesis. Due to their non-tumorigenicity, low immunogenicity, and therapeutic potential, EVs are increasingly used in cardiac repair as cell-free therapy. There exist multiple steps for the design of EV therapies, and each step offers many choices to tune EV properties. Factors such as EV source, cargo, loading methods, routes of administration, surface modification, and biomaterials are comprehensively considered to achieve specific goals. PubMed and Google Scholar were searched in this review, 89 articles related to EV-based cardiac therapy over the past five years (2019 Jan - 2023 Dec) were included, and their key steps in designing EV therapies were counted and analyzed. We aim to provide a comprehensive overview that can serve as a reference guide for researchers to design EV-based cardiac therapies.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 12-32"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation MAPK14/AIFM2通路调节线粒体自噬依赖性细胞凋亡改善心房颤动。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.002
Lu Wang , Wanyue Sang , Yi Jian , Yafan Han , Feifei Wang , Subinuer Wubulikasimu , Li Yang , Baopeng Tang , Yaodong Li

Objectives

To investigate the role and mechanism of MAPK14/AIFM2 pathway in Ang II-induced atrial fibrillation in rats.

Methods

A rat model of AF was established for in vivo experiments and HL-1 cells were treated with Ang II to develop an in vitro model. In addition, HL1 cells overexpressing AIFM2 (oeAIFM2) were constructed. SB203580 was used to inhibit the expression of MAPK14. The role of MAPK14 in Ang II-AF model was investigated by in vivo electrophysiological examination and molecular biology tests. The role of MAPK14 / AIFM2 pathway on AF induced by Ang II was explored in vitro.

Results

MAPK14 and AIFM2 were significantly up-regulated in AF induced by Ang II (all P < 0.05). In vivo experiments indicated that inhibition of MAPK14 down-regulated AIFM2, improved atrial electrical conduction, AF inducibility and durations, and alleviated the structural and functional damage of heart and mitochondria (all P < 0.05). Both in vivo and in vitro tests showed that the MAPK14/AIFM2 pathway prevented Ang II-induced AF via regulating mitophagy-dependent apoptosis.

Conclusions

Inhibition of the MAPK14/AIFM2 pathway improved Ang II-induced AF by inhibiting mitophagy-dependent apoptosis.
目的:探讨MAPK14/AIFM2通路在Angⅱ型心房颤动中的作用及机制。方法:建立AF大鼠模型进行体内实验,并用Angⅱ处理HL-1细胞建立离体模型。构建过表达AIFM2的HL1细胞(oeAIFM2)。使用SB203580抑制MAPK14的表达。通过体内电生理检查和分子生物学检测,探讨MAPK14在Ang II-AF模型中的作用。探讨MAPK14 / AIFM2通路在Angⅱ诱导AF中的作用。结果:MAPK14和AIFM2在Ang II诱导的AF中显著上调(P均为 )。结论:抑制MAPK14/AIFM2通路通过抑制线粒体自噬依赖性凋亡改善Ang II诱导的AF。
{"title":"MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation","authors":"Lu Wang ,&nbsp;Wanyue Sang ,&nbsp;Yi Jian ,&nbsp;Yafan Han ,&nbsp;Feifei Wang ,&nbsp;Subinuer Wubulikasimu ,&nbsp;Li Yang ,&nbsp;Baopeng Tang ,&nbsp;Yaodong Li","doi":"10.1016/j.yjmcc.2024.12.002","DOIUrl":"10.1016/j.yjmcc.2024.12.002","url":null,"abstract":"<div><h3>Objectives</h3><div>To investigate the role and mechanism of MAPK14/AIFM2 pathway in Ang II-induced atrial fibrillation in rats.</div></div><div><h3>Methods</h3><div>A rat model of AF was established for in vivo experiments and HL-1 cells were treated with Ang II to develop an in vitro model. In addition, HL1 cells overexpressing AIFM2 (oeAIFM2) were constructed. SB203580 was used to inhibit the expression of MAPK14. The role of MAPK14 in Ang II-AF model was investigated by in vivo electrophysiological examination and molecular biology tests. The role of MAPK14 / AIFM2 pathway on AF induced by Ang II was explored in vitro.</div></div><div><h3>Results</h3><div>MAPK14 and AIFM2 were significantly up-regulated in AF induced by Ang II (all <em>P</em> &lt; 0.05). In vivo experiments indicated that inhibition of MAPK14 down-regulated AIFM2, improved atrial electrical conduction, AF inducibility and durations, and alleviated the structural and functional damage of heart and mitochondria (all <em>P</em> &lt; 0.05). Both in vivo and in vitro tests showed that the MAPK14/AIFM2 pathway prevented Ang II-induced AF via regulating mitophagy-dependent apoptosis.</div></div><div><h3>Conclusions</h3><div>Inhibition of the MAPK14/AIFM2 pathway improved Ang II-induced AF by inhibiting mitophagy-dependent apoptosis.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 1-11"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of rare missense TTN variants in a cohort of patients with cardiomyopathy 心肌病患者队列中罕见的错义 TTN 变异的流行率。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.004
Irene Bottillo , Maria Pia Ciccone , Monia Magliozzi , Kalliopi Pilichou , Giorgia Girotto , Francesca Girolami , Massimiliano Cecconi , Valeria D'Argenio , Valeria Novelli , Alessandra Coiana , Daniela Formicola , Emanuele Micaglio , Giada Tortora , Francesca Gualandi , Simona Petrucci , Italian Cardiogenetics Study Group, Marco Castori , Nicoletta Resta , Anna Rita Vestri , Maria Iascone , Paola Grammatico
{"title":"Prevalence of rare missense TTN variants in a cohort of patients with cardiomyopathy","authors":"Irene Bottillo ,&nbsp;Maria Pia Ciccone ,&nbsp;Monia Magliozzi ,&nbsp;Kalliopi Pilichou ,&nbsp;Giorgia Girotto ,&nbsp;Francesca Girolami ,&nbsp;Massimiliano Cecconi ,&nbsp;Valeria D'Argenio ,&nbsp;Valeria Novelli ,&nbsp;Alessandra Coiana ,&nbsp;Daniela Formicola ,&nbsp;Emanuele Micaglio ,&nbsp;Giada Tortora ,&nbsp;Francesca Gualandi ,&nbsp;Simona Petrucci ,&nbsp;Italian Cardiogenetics Study Group,&nbsp;Marco Castori ,&nbsp;Nicoletta Resta ,&nbsp;Anna Rita Vestri ,&nbsp;Maria Iascone ,&nbsp;Paola Grammatico","doi":"10.1016/j.yjmcc.2024.12.004","DOIUrl":"10.1016/j.yjmcc.2024.12.004","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 46-50"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy klf2依赖性转录调控保护心脏免受病理性肥厚。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2024.12.010
Yongqi Wu , Yujuan Song , Nan Xie , Wanqing Zhao , Jian Lv , Tingting Zhang , Yang Zhang , Hongyin Chen , Weiyun Sun , Zhenyu Luo , Xinhui Cheng , Tao Jiang , Zhihua Wang , Xiaoling Chen , Yu Hu , Yu Fang , Rui Bai , Xujie Liu , Xia He , Zongna Ren , Li Wang

Background

Our previous single-cell RNA sequencing study in the adult human heart revealed that cardiomyocytes from both the atrium and ventricle display high activities of Krüppel-like factor 2 (KLF2) regulons. However, the role of the transcription factor KLF2 in cardiomyocyte biology remains largely unexplored.

Methods and results

We employed transverse aortic constriction surgery in male C57BL/6 J mice to develop an in vivo model of cardiac hypertrophy, and generated different in vitro cardiac hypertrophy models in neonatal rat ventricular myocytes and human embryonic stem cell-derived cardiomyocytes. Our results demonstrated a significant reduction in KLF2 expression during the progression of cardiac hypertrophy. In vitro, Klf2 deficiency exacerbates cardiac hypertrophy and enhances hypertrophic reprogramming, while KLF2 overexpression attenuates cardiac hypertrophy and reverses hypertrophic transcriptome reprogramming. Mechanistically, combined RNA-seq and cleavage under targets & tagmentation (CUT&Tag) analysis revealed that KLF2 exerts its protective effects by directly regulating a set of genes associated with cardiac hypertrophy. In vivo, KLF2 overexpression specifically in cardiomyocytes effectively prevents TAC-induced cardiac hypertrophy in mice. Additionally, we found that simvastatin elevates KLF2 expression in cardiomyocytes, which subsequently alleviates cardiomyocyte hypertrophy.

Conclusions

This study provides the first evidence that transcription factor KLF2 serves as a negative regulator of cardiac hypertrophy. Our findings highlight the therapeutic potential of enhancing KLF2 expression, particularly through simvastatin administration, as a promising strategy in the treatment of cardiac hypertrophy.
背景:我们之前在成人心脏中进行的单细胞RNA测序研究表明,心房和心室的心肌细胞都显示出kr样因子2 (KLF2)调控的高活性。然而,转录因子KLF2在心肌细胞生物学中的作用在很大程度上仍未被探索。方法与结果:采用雄性C57BL/6 J小鼠主动脉横断缩窄术建立体内心肌肥厚模型,并以新生大鼠心室肌细胞和人胚胎干细胞源性心肌细胞制备不同的体外心肌肥厚模型。我们的研究结果表明,在心脏肥厚的过程中,KLF2的表达显著降低。在体外,Klf2缺乏会加剧心脏肥厚并增强肥厚重编程,而Klf2过表达会减弱心脏肥厚并逆转肥厚转录组重编程。在机制上,结合RNA-seq和切割靶与标记(CUT&Tag)分析发现,KLF2通过直接调节一组与心肌肥厚相关的基因发挥其保护作用。在体内,KLF2在心肌细胞特异性过表达可有效预防tac诱导的小鼠心肌肥厚。此外,我们发现辛伐他汀可提高心肌细胞中KLF2的表达,从而减轻心肌细胞肥厚。结论:本研究首次证明转录因子KLF2在心肌肥厚中起负调节作用。我们的研究结果强调了增强KLF2表达的治疗潜力,特别是通过给药辛伐他汀,作为治疗心脏肥厚的一种有希望的策略。
{"title":"KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy","authors":"Yongqi Wu ,&nbsp;Yujuan Song ,&nbsp;Nan Xie ,&nbsp;Wanqing Zhao ,&nbsp;Jian Lv ,&nbsp;Tingting Zhang ,&nbsp;Yang Zhang ,&nbsp;Hongyin Chen ,&nbsp;Weiyun Sun ,&nbsp;Zhenyu Luo ,&nbsp;Xinhui Cheng ,&nbsp;Tao Jiang ,&nbsp;Zhihua Wang ,&nbsp;Xiaoling Chen ,&nbsp;Yu Hu ,&nbsp;Yu Fang ,&nbsp;Rui Bai ,&nbsp;Xujie Liu ,&nbsp;Xia He ,&nbsp;Zongna Ren ,&nbsp;Li Wang","doi":"10.1016/j.yjmcc.2024.12.010","DOIUrl":"10.1016/j.yjmcc.2024.12.010","url":null,"abstract":"<div><h3>Background</h3><div>Our previous single-cell RNA sequencing study in the adult human heart revealed that cardiomyocytes from both the atrium and ventricle display high activities of Krüppel-like factor 2 (KLF2) regulons. However, the role of the transcription factor KLF2 in cardiomyocyte biology remains largely unexplored.</div></div><div><h3>Methods and results</h3><div>We employed transverse aortic constriction surgery in male C57BL/6 J mice to develop an <em>in vivo</em> model of cardiac hypertrophy, and generated different <em>in vitro</em> cardiac hypertrophy models in neonatal rat ventricular myocytes and human embryonic stem cell-derived cardiomyocytes. Our results demonstrated a significant reduction in KLF2 expression during the progression of cardiac hypertrophy. <em>In vitro</em>, <em>Klf2</em> deficiency exacerbates cardiac hypertrophy and enhances hypertrophic reprogramming, while KLF2 overexpression attenuates cardiac hypertrophy and reverses hypertrophic transcriptome reprogramming. Mechanistically, combined RNA-seq and cleavage under targets &amp; tagmentation (CUT&amp;Tag) analysis revealed that KLF2 exerts its protective effects by directly regulating a set of genes associated with cardiac hypertrophy. <em>In vivo</em>, KLF2 overexpression specifically in cardiomyocytes effectively prevents TAC-induced cardiac hypertrophy in mice. Additionally, we found that simvastatin elevates KLF2 expression in cardiomyocytes, which subsequently alleviates cardiomyocyte hypertrophy.</div></div><div><h3>Conclusions</h3><div>This study provides the first evidence that transcription factor KLF2 serves as a negative regulator of cardiac hypertrophy. Our findings highlight the therapeutic potential of enhancing KLF2 expression, particularly through simvastatin administration, as a promising strategy in the treatment of cardiac hypertrophy.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 62-77"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to commentary from Song et al. 对Song等人评论的回应。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.yjmcc.2025.01.002
Satadru K. Lahiri , Stephan E. Lehnart , Svetlana Reilly , Xander H.T. Wehrens
{"title":"Response to commentary from Song et al.","authors":"Satadru K. Lahiri ,&nbsp;Stephan E. Lehnart ,&nbsp;Svetlana Reilly ,&nbsp;Xander H.T. Wehrens","doi":"10.1016/j.yjmcc.2025.01.002","DOIUrl":"10.1016/j.yjmcc.2025.01.002","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"199 ","pages":"Pages 78-79"},"PeriodicalIF":4.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of molecular and cellular cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1